Angiographic Findings in COVID-19 Patients Presenting with ST-elevation Myocardial Infarction | ||
| Journal of Current Medical Research and Practice | ||
| Volume 10, Issue 4, October 2025, Pages 73-80 PDF (416.77 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/jcmrp.2025.372880.1255 | ||
| Authors | ||
| Amr E Abouelnour; Mohamed AB Naqady* ; Hosam Hasan Ali | ||
| Cardiology Department, Faculty of Medicine, Assiut University, Assiut, Egypt. | ||
| Abstract | ||
| Abstract: Background: Even though viral pneumonia is the most common clinical manifestation of COVID-19, myocardial injury is also common and can have a variety of causes, including myocardial infarction. Our goal is to examine the results of invasive coronary angiography (ICA) in COVID-19 patients who present with ST-elevation myocardial infarction (STEMI). Methods: Twenty-six consecutive patients confirmed to have COVID-19 and STEMI were screened from October 2020 to October 2022. Emergent invasive strategy (primary PCI [PPCI]) was done in 22 cases, whereas the remaining patients treated medically were excluded. Results: Almost one third of patients (31.8%) who underwent PPCI had non-obstructed coronary arteries on invasive angiography (labelled MINOCA). Conclusion: Atypical MI-like presentations are common in COVID-19 patients, including the absence of a culprit coronary lesion (referred to as MINOCA). These unusual manifestations suggest that myocyte damage may be caused by causes other than the cessation of coronary artery flow. Additional research, including cardiac MRI, is necessary to clarify those pathways. | ||
| Keywords | ||
| Keywords: COVID-19; Myocardial infarction (MI); Myocardial infarction with no obstructive coronary artery (MINOCA); Invasive coronary angiography (ICA) | ||
|
Statistics Article View: 7 PDF Download: 12 |
||
